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Abstract 
Non-medical use of prescription drugs (NMUPD) by adolescents is a significant public 
health concern. The present study investigated whether NMUPD is associated with future 
delinquency using baseline, 6-month, and 12-month follow-up data of 1,349 adolescent offenders 
from the Pathways to Desistance project. Results indicated baseline differences across three 
NMUPD use groups on demographic factors, violence exposure, mental health diagnoses, other 
drug use, and previous delinquency, suggesting that severity of NMUPD is important to 
consider. Further, NMUPD significantly predicted drug-related, non-aggressive, and aggressive 
delinquency 12 months later even after considering other known correlates of delinquency. 
Analyses suggest that NMUPD contributes to future delinquency in part because NMUPD users 
are exposed to violence, have enduring mental health and drug use problems, and have 
delinquency histories. These findings suggest that NMUPD is an important component of future 
delinquency for adolescent offenders but it should be considered within the context of other 
known risk factors. 
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1. Introduction 
Over the last two decades opioids and other psychotherapeutic medications, such as 
tranquilizers, stimulants, and sedatives have been prescribed in greater frequency in the United 
States, especially to adolescents and young adults (Fortuna, Robbins, Caiola, Joynt, & 
Halterman, 2010; Thomas, Conrad, Casler, & Goodman, 2006). Coupled with a corresponding 
increase in the non-medical use and abuse of those drugs, this has been topic of controversy and 
reason for great concern (Ford, 2008; Manchikanti & Singh, 2008; Novak, Calvin, Glasheen, & 
Edlund, 2011; Thomas et al., 2006; Young, Glover, & Havens, 2012).  
The National Survey on Drug Use and Health (NSDUH) defines non-medical use of 
prescription drugs (NMUPD) as use of at least one psychotherapeutic drug from four categories 
of prescription-type drugs (i.e., opioids, tranquilizers, stimulants, and sedatives) “without a 
prescription of the individual's own or simply for the experience or feeling the drugs caused” 
(Substance Abuse and Mental Health Services Administration (SAMHSA), 2013b). National 
estimates of substance use in the general population show that the use of non-medical 
prescription drugs has become more prevalent than the use of other illicit drugs with the 
exception of marijuana; 2.4 million Americans engaged in NMUPD for the first time within the 
past year in 2012, an average of 6,700 initiates per day (SAMHSA, 2013b). This is a significant 
public health concern: prescription opioid abuse alone was estimated to cost the U.S. $55.7 
billion in 2007 (Birnbaum et al., 2011).  
1.1. Adolescent Substance Use, Delinquency and NMUPD 
As with other forms of substance use, findings indicate that adolescents and young adults 
are at the greatest risk of NMUPD relative to other age groups (Novak, Calvin, Glasheen, & 
Edlund, 2011; SAMHSA, 2006, 2013b), and numerous studies have explored NMUPD among 
adolescents (Ford, 2008; Johnston, O’Malley, Bachman, & Schulenberg, 2011; Young et al., 
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2012). NMUPD was the second most popular illicit drug for adolescents after marijuana in a 
nationally representative community sample, with a peak of 4.0 % past month users among 16 
and 17 year olds in the 2013 NSDUH. This finding extended to 12 to 13 year olds: NMUPD was 
the most prevalent illicit drug used, with 1.7 % reporting past month use (SAMHSA, 2013b). In 
2009, the NSDUH showed that among all past year adolescent users about 16% met the criteria 
for abuse or dependence, indicating that problematic levels of abuse are developing far earlier in 
life course compared to other illicit drugs such as cocaine or heroin, where the median age of 
abuse and dependence is situated in the mid-20s (Novak et al., 2011). 
Beyond abuse and dependence, studies investigating life experiences and mental health 
symptoms have found that trauma, a history of significant witnessed violence, post-traumatic 
stress disorder (PTSD), and major depressive disorder (MDD) were associated with adolescent 
NMUPD use (Catalano, White, Fleming, & Haggerty, 2011; McCauley et al., 2010; Schepis & 
Krishnan-Sarin, 2008). Further, NMUPD use has been linked with poor school performance and 
lower school bonding (Ford, 2009; Schepis & Krishnan-Sarin, 2008) and delinquency (Ford, 
2008). Overall, NMUPD users are at an increased risk for emergency room visits (SAMHSA, 
2013a) and death (Centers for Disease Control and Prevention (CDC), 2012; Paulozzi et al., 
2012). Youth who engage in NMUPD are significantly more likely than their peers to use other 
illicit drugs and to combine prescription drugs with alcohol and other substances. These practices 
not only further increase the risk of involvement with the juvenile justice system, they also lead 
to increased risk for potentially dangerous drug interactions and their negative outcomes (Garnier 
et al., 2009; McCabe, Teter, & Boyd, 2006).  
Clearly, NMUPD among juveniles is a large public health problem with significant 
consequences, yet studies investigating NMUPD in adolescent samples indicate that there is 
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considerable variation in both prevalence of NMUPD and demographic, behavioral, and social 
correlates (Boyd, Young, Grey, & McCabe, 2009; Young et al., 2012). For example, in general 
NMUPD has been lower among racially and ethnically non-White adolescents compared to their 
White counterparts (McCabe, West, Teter, & Boyd, 2012; McCauley et al., 2010; SAMHSA, 
2013b). Overall prevalence rates and trends in high risk samples of adolescents are missing from 
the literature.  
Adolescents are more likely than young adults to use multiple drugs, and a plethora of 
evidence suggests that there is a substantial overlap in NMUPD and the use of marijuana and 
other illicit drugs (Boyd, Young, Grey, & McCabe, 2009; Catalano et al., 2011; Ford, 2008; 
McCabe et al., 2012; Schepis & Krishnan-Sarin, 2008; SAMHSA, 2013b; Wu, Schlenger, & 
Galvin, 2006; Young et al., 2012). Several researchers have thus suggested that NMUPD might 
simply be another form of illicit substance use, and that negative consequences of NMUPD 
might overlap with symptoms of polydrug use (Catalano et al., 2011; Ford, 2008; Young et al., 
2012). Possible explanations of the relationship between illicit substance use, alcohol, and 
NMUPD is that an adolescent who already is abusing substances might share some of the risk 
factors associated with NMUPD; he or she might already know where and how to access 
prescription drugs and receive less parental monitoring compared to non-using peers. 
Additionally, adolescents who binge drink, abuse alcohol, or use other illicit drugs may engage 
in NMUPD for similar affective reasons – either an attempt to numb affect or experience 
excitement (McCauley et al., 2010). There is some support for this hypothesis in data linking 
NMUPD to delinquency, with one study of students finding that NMUPD motivated by thrill-
seeking, but not motivated by self-treatment, was connected to both other illicit drug use and 
delinquency (Boyd et al., 2009).  
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A wealth of research documents the association between illicit drug use and increased 
risk of general and aggressive delinquency among adolescents (Adams et al., 2013; Barnes, 
Welte, & Hoffman, 2002; Doran, Luczak, Bekman, Koutsenok, & Brown, 2012; Ford, 2008; 
Mason & Windle, 2002). Substance use has been associated with continuity in offending, 
decreased likelihood of desistance, and increased risk of reoffending; it also distinguished high 
level chronic offenders from less severe offender groups (Mulvey, Schubert, & Chassin, 2010; 
Schubert, Mulvey, & Glasheen, 2011). While comparatively more limited than the general 
literature, there is some evidence that links NMUPD specifically with delinquency in adolescents 
(Adams et al., 2013; Boyd et al., 2009; Catalano et al., 2011; Sung, Richter, Vaughan, Johnson, 
& Thom, 2005). One of the few studies focusing on NMUPD and delinquency is Ford’s (2008) 
analysis of the connection between NMUPD and delinquency in the community sample of the 
2005 NSDUH. In this study, results indicated that NMUPD overall, as well as specific categories 
of drugs (i.e., opioids, tranquilizers stimulants, and sedatives), were significantly associated with 
self-reported general delinquency in adolescents. Further, overall NMUPD and the non-medical 
use of opioids were associated with increased likelihood of arrest among 12 to 17 year old 
adolescents. The study found that in this sample, the use of other illicit drugs (not including 
marijuana) was more strongly associated with self-reported general delinquency and arrest than 
NMUPD. However, severity of drug use and use of marijuana were not included in the analyses 
and differential relationships of NMUPD to aggressive versus non-aggressive or drug-related 
delinquency were not investigated.  
Evidence regarding differential relationships of illicit drug use, alcohol use, and different 
types of delinquency is comparatively more equivocal than the relationship to general 
delinquency. Data from the most recent NSDUH shows that youths aged 12 to 17 who had 
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engaged in fighting or other delinquent behaviors in the past year were more likely than other 
youths to have used illicit drugs in the past month (SAMHSA, 2013b).These findings suggest 
that among adolescents in the community, illicit drug use compared with NMUPD is more 
directly associated with non-violent property-related crime. In contrast however, a wealth of 
research has shown that substance use confers an increased risk for aggression (versus general 
delinquency), with early use a particularly strong predictor of violent behavior (Doran et al., 
2012; Hawkins et al., 2000; Martel et al., 2009). Relationships between NMUPD and different 
delinquent behaviors have not yet been assessed, even though there is some evidence of potential 
differences in the association of NMUPD and different forms of delinquency. One longitudinal 
study found that the non-medical use of prescription opioids among adolescents was associated 
with violent behavior, but explained little variance in property crime (Catalano et al., 2011), and, 
as stated above, a study with high-school students found that only NMUPD motivated by 
sensation seeking, and not self-treatment, was associated with delinquency (Boyd et al., 2009). 
However, in a sample of justice system-involved, high-risk youth, substance use was equally 
related to drug-related, interpersonal, and property delinquency with stability over time 
(D’Amico, Edelen, Miles, & Morral, 2008). 
1.2. Substance Use and NMUPD among Juvenile Offenders 
The increased prevalence of mental health problems and substance use disorders together 
with an elevated rate of substance use among juvenile offenders in the juvenile justice system is 
a well-known issue (Chassin, 2008; Shook, Vaughn, Goodkind, & Johnson, 2011; Vaughn, 
Freedenthal, Jenson, & Howard, 2007; Vaughn, Howard, Foster, Dayton, & Zelner, 2005). As 
mentioned above, substance use disorders are linked to continued offending and violence in 
community and offender samples of adolescents (Adams et al., 2013; Chassin, 2008; Mulvey et 
NMUPD IN ADOLESCENT OFFENDERS  8 
al., 2004a). Among juvenile offenders, the presence of a substance use disorder is consistently 
associated with more re-arrests, more self-reported antisocial activity, more drug-related, 
interpersonal, and property delinquency, and less engagement in gainful activity, both cross-
sectionally and over time (D’Amico et al., 2008; Mulvey et al., 2004a; Schubert et al., 2011).  
Our knowledge of prevalence and correlates of NMUPD among this high-risk population 
is limited to a few studies examining correlates of mostly binary lifetime NMUPD in currently 
incarcerated samples. One of the few studies taking into account the severity of drug use in this 
population examined patterns of illicit drug use and mental health concerns among a state 
population of 723 incarcerated juvenile offenders and found that level of lifetime poly-substance 
use and severity of problems stemming from alcohol and drug use were associated with severity 
of mental health symptoms, including past traumatic experiences (Vaughn et al., 2007). Links 
between drug use and delinquency or NMUPD specifically were not assessed. The only study 
examining the correlates of NMUPD in a sample of confined adolescents was conducted with the 
population of one urban detention center in Ohio (Alemagno, Stephens, Shaffer-King, & 
Teasdale, 2009). It showed that overall 10% of incarcerated male youth reported lifetime 
NMUPD. Arrestees reporting NMUPD had higher levels of overall other illicit drug use, more 
alcohol problems, reported more trauma and problems with anger management, as well as more 
risky sexual behaviors. However, frequency or recency of NMUPD use as well as any relation to 
non-aggressive or drug-related delinquency was not reported. Finally, there was one study with 
227 incarcerated juveniles comparing youthful offenders who sold drugs with those who did not 
sell drugs on substance use and other behaviors (Shook et al., 2011). Results suggested that 
juveniles engaging in either selling marijuana or hard drugs were using marijuana use, other 
illicit drugs, and NMUPD at substantially elevated rates, suggesting a significant overlap 
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between own substance use and dealing of drugs. In summary, there is sparse knowledge about 
NMUPD use specifically among adolescent offenders. Given the high prevalence of substance 
use, mental health issues and thrill-seeking behaviors in offenders, they are at increased risk for 
the NMUPD. Given national trends in NMUPD it seems especially important to understand the 
unique contribution of NMUPD to future patterns of delinquency and other substance use.  
Investigating whether NMUPD uniquely contributes to patterns of recidivism has potentially 
important implications for treatment of substance use problems and targeted prevention efforts in 
this population.   
1.3. Current Study 
The present study contributes to the literature in several ways. Serious adolescent 
offenders are a group with an especially elevated risk of engaging in both substance use and 
continued delinquency. While there is some evidence that NMUPD is associated with 
delinquency in community samples, limited data on the characteristics of NMUPD users among 
serious adolescent offenders exists. Additionally, the existing knowledge about NMUPD use 
among offenders largely stems from incarcerated samples reporting on past behavior; there is a 
dearth of longitudinal research that investigates how NMUPD influences delinquency over time 
above and beyond known correlates of delinquency. The present study describes and compares 
serious juvenile offenders who have never engaged in NMUPD, engaged in NMUPD only 
experimentally or long ago, and recent frequent users. Further, the present study investigates the 
relationship between NMUPD and different forms of delinquency; there are no studies to date 
that investigate the influence of NMUPD on drug-related, non-aggressive, and aggressive 
delinquency separately. Finally, the present study investigates these relationships longitudinally 
and investigates NMUPD influences on different types of future delinquency above and beyond 
NMUPD IN ADOLESCENT OFFENDERS  10 
other known correlates of delinquency, closing a substantial gap in knowledge, and providing 
data that can inform prevention and treatment of this high-risk group of adolescent offenders.  
Thus, the purposes of the current study were to investigate two research questions: (1) 
What is the profile of NMUPD among serious juvenile offenders? and (2) What is the unique 
contribution of NMUPD in predicting future drug-related, non-aggressive, and aggressive 
delinquency among serious adolescent offenders beyond known correlates of delinquency? 
2. Materials and methods 
2.1. Participants 
The present article is a secondary data analysis from the Pathways to Desistance project, 
a multisite, longitudinal study of serious juvenile offenders (Mulvey et al., 2004b). Beginning in 
2000, project staff recruited 1,354 adolescents aged 14 through 17 who were adjudicated 
delinquent, or found guilty of a serious (overwhelmingly felony-level) offense, at their current 
court appearance in Philadelphia, PA (N = 654) and Phoenix, AZ (N = 700). The number of 
males adjudicated for a drug offense was capped at 15% of the sample so as to avoid 
overrepresentation of drug offenders. All females and all youth transferred to the adult system 
who met the enrollment criteria also were recruited to participate. 
Immediately after enrollment, researchers conducted a structured 4-hour baseline 
interview with each adolescent. The interview included a thorough assessment of the youth’s 
social background, developmental history, psychological functioning, psychosocial maturity, 
attitudes about illegal behavior, intelligence, school achievement and engagement, work 
experience, mental health, current and previous substance use and abuse, family and peer 
relationships, use of social services, and antisocial behavior. After the baseline interview, 
researchers interviewed participants every six months for the three years and annually thereafter. 
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At each follow-up interview, researchers gathered information on the adolescent’s self-reported 
behavior and experiences during the prior 6 months, including any illegal activity, drug or 
alcohol use, and involvement with treatment or other services. In addition, the follow-up 
interviews collected data on changes in life situations (e.g., living arrangements and 
employment), developmental factors (e.g., likelihood of thinking about and planning for the 
future and relationships with parents), and functional capacities (e.g., mental health symptoms). 
The current study uses data from the baseline, 6-month follow-up and 12-month follow-up 
interviews only (retention rates = 93% of the full sample). Additional details regarding the study 
rationale can be found in Mulvey and colleagues (2004), and additional details regarding the 
study design, sample, and methodology are in Schubert and colleagues (2004). 
Five participants were missing data on NMUPD and therefore were not included in our 
analyses (N = 1,349). The majority of the selected sample was male (86%, n = 1,165). The 
race/ethnicity of the sample was 41% Black, 34% Hispanic, 20% White, and 5% other. The 
participants’ average age was 16.04 years (SD = 1.14 years). The most common family structure 
was a youth with their biological mother who was single and never married (21%), followed by 
biological mother and step-father (18%), biological mother who was single and divorced or 
separated (16%), two biological parents (15%), other adult relative (12%), no adult in home 
(5%), and other (13%).  
2.2. Measures 
2.2.1. Demographics. A single item represented race/ethnicity (i.e., White, Black, 
Hispanic, Other), and a single item assessed gender (1 = male, 2 = female); age in years was a 
continuous variable. 
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Socioeconomic status (SES) was based on both parental education and occupation. 
Reported parental occupation and education were coded using a seven-point scale ranging from 1 
(higher executives, proprietors, major professionals; professional degree) to 7 (unskilled 
employees; less than seven years of school) based on Hollingshead's index of social position (see 
Hollingshead, 1957). Then, a parental Index of Social Position (ISP) which is based on the 
formula ((Occupation score x 7) + (Education score x 4)) was computed (see Hollingshead, 
1970). When both the occupation and education for the parent was unknown, the individual 
parent ISP score was not computed. If only one of the two components was known, the missing 
information was derived using the available data. The mean of the mother and father occupation 
and education was taken when data for both parents were available. 
Proportion of time spent in facilities with no community access was also assessed at the 
6-month and 12-month follow-up interviews. This value was a proportion indicating the total 
days during the recall period that the participant was reported to be in a facility with no 
community access. The average of the proportion from the two time points was used in the 
current study.  
2.2.2. Violence exposure. The Exposure to Violence Inventory (ETV; Selner-O’Hagan, 
Kindlon, Buka, Raudenbush, & Earls, 1998) was modified for this study to assess the frequency 
of exposure to violent events. Items document the types of violence the adolescent both 
experienced (i.e., Victim - 6 items, e.g., ‘‘Have you ever been chased where you thought you 
might be seriously hurt?’’) and observed (i.e., Witnessed - 7 items, e.g., ‘‘Have you ever seen 
someone else being raped, an attempt made to rape someone or any other type of sexual 
attack?’’). A total score was created that summed the victim and witness items that were 
endorsed. Higher scores indicate greater exposure to violence. 
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2.2.3. Mental health. The Composite International Diagnostic Interview (CIDI; World 
Health Organization, 1990) is a comprehensive, fully structured interview used to assess mental 
disorders. By means of computerized algorithms, the CIDI provides both lifetime ("Ever") and 
current ("Past year" and "Past 30 days") diagnosis as defined by the DSM-IV and ICD-10. The 
entire CIDI was not administered and the following six modules were selected for the purpose of 
the current study: major depressive disorder (MDD), posttraumatic stress disorder (PTSD), 
alcohol abuse, alcohol dependence, drug abuse, and drug dependence. During the interview, all 
participants were asked questions about selective symptoms of psychiatric disorders. Based on 
predetermined skip patterns, positive responses to these screening items were followed by more 
detailed questions to determine if the endorsed symptom is a psychiatric symptom and is not due 
to medication, drugs, alcohol, or to a physical illness or injury. If symptoms were endorsed and 
occurred in a pattern which suggested a diagnosis might be present, additional questions were 
asked to establish the onset and recency of the symptoms. Participants were either given a 
diagnosis or not for lifetime, past year, and past 30 days on all selected diagnoses. Additionally, 
a severity scale was calculated. For each disorder participants were coded either “0 – Never had 
diagnosis,” “1 – Had diagnosis in lifetime,” “2 – Had diagnosis in past year,” or “3 – Had 
diagnosis in past 30 days.” Higher scores indicated a more frequent diagnosis. 
2.2.4. Drug use. A modified version of The Substance Use/Abuse Inventory, developed 
by Chassin, Rogosch, and Barrera (1991) for use in a study of children of alcoholics was used to 
assess adolescent's self-reported use of illegal drugs and alcohol over the course of his/her 
lifetime and in the past 6-months (e.g., "How often have you had alcohol to drink?"). The current 
study only used the Substance Use subscale to measure use of alcohol, marijuana, and other 
illicit drugs (i.e., cocaine, opioids, ecstasy, hallucinogens). Additionally, youth were asked 
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whether they have used sedatives (e.g., sleeping pills, barbiturates, seconal, valium, librium, 
xanax, qualludes, etc.) or stimulants (e.g., diet pills, benzadrine, methamphetamine) to get high, 
and if so how frequently (0 = Not at all to 9 = Everyday). These questions were used to assess 
NMUPD.  
2.2.5. Delinquency history. A modified version of the Self-Report of Offending (SRO; 
Elliott, 1990; Huizinga, Esbensen, & Weiher, 1991) scale was used at each interview to measure 
the adolescent’s account of his/her involvement in three drug-related delinquent acts (i.e., selling 
marijuana, selling other illegal drugs, driving while intoxicated or high), six non-aggressive 
delinquent acts (i.e., breaking in to steal, shoplifting, buying/receiving/selling stolen property, 
using checks or credit cards illegally, stealing a car or motorcycle, carjacking, being paid by 
someone for sex), and 11 different aggressive delinquent acts (i.e., destroying/damaging 
property, setting fires, forcing someone to have sex, killing someone, shooting at someone 
(bullet hit or did not hit), robbery with weapon, robbery without weapon, assault, fights, fights as 
part of gang activity). For each endorsed item at baseline, the follow-up question "How many 
times have you done this in the past year?" was asked. This item was used to identify whether the 
adolescent reported doing an act within the past six months. At the follow-up interviews the 
participants were again asked if they engaged in any of these activities since the last interview. A 
sum of the number of items endorsed was divided by the number of questions answered to 
produce a ‘‘general variety’’ proportion score (range 0 to 1) for each participant for drug-related, 
non-aggressive, and aggressive delinquency. This score assessed the number of different types of 
delinquent acts in which the participant engaged and was used in the current study as a severity 
index for delinquency. Higher scores indicate more varied, and hence severe, delinquency 
patterns.  
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2.3. Data analysis 
 Analyses were performed using SPSS Version 21 (IBM Corp., 2012). Three mutually 
exclusive groups were created to assess frequency and current NMUPD at baseline. The first 
group consisted of youth who reported no NMUPD (i.e., no NMUPD of either stimulants or 
sedatives); the second group comprised youth who had engaged in NMUPD but less than at least 
once a month in the past six months; youth in the third group reported NMUPD at least once a 
month in the past six months. Then, univariate tests of differences between the three groups on 
demographic, violence exposure, mental health, other drug use, and delinquency history 
variables were tested either with 2 (for categorical variables) or one-way analysis of variance 
(ANOVA; for continuous variables). In these analyses race/ethnicity was dichotomized (1 = 
White, 0 = all others). 
Next, to assess future delinquency across the following 12 months from baseline, the 
average variety proportion score was calculated from the 6-month and 12-month follow-ups for 
each area of delinquency: drug-related, non-aggressive, and aggressive. The mean of the reported 
offending history proportion score was used to capture the variety of delinquency from baseline 
to 6-months and then from 6-months to 12-months. 
Then, a series of six analyses of covariance (ANCOVAs) models predicting delinquency 
across 12 months were estimated separately for drug-related delinquency, non-aggressive 
delinquency, and aggressive delinquency. Each type of delinquency was studied separately as 
previous research has suggested that what predicts one type of delinquency may be different 
from what predicts other types of delinquency (Catalano et al., 2011). Also, each set of 
covariates was grouped and analyzed separately to determine the relative importance of NMUPD 
within each domain. The demographic model included race/ethnicity, sex, age, and SES as 
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covariates. Additionally, to account for the effect of institutional confinement on the adolescent’s 
level of delinquency (Piquero et al., 2001), proportion of time with no community access was 
added as an additional covariate in the analyses. All of the following models included the 
demographic variables and a unique set of covariates known to also be involved in future 
delinquency; the covariates were not continually added from one model to the next. The second 
model added total violence exposure as a covariate to the demographic variables. The third 
model, the mental health model, added the severity scores for MDD, PTSD, alcohol abuse, 
alcohol dependency, drug abuse, and drug dependency as covariates to the demographic 
variables. The fourth model added the youth’s lifetime use of alcohol, marijuana, and illicit drugs 
as covariates; while the fifth model added the youth’s lifetime history of drug-related 
delinquency, non-aggressive delinquency, and aggressive delinquency to the demographic 
covariates. The sixth, and final model, included all the significant covariates from previous 
analyses in the model and the demographic variables. Planned contrast tests were then conducted 
to determine the specific group differences when the F-statistic was significant. All analyses 
utilizing continuous variables used Bonferonni correction to adjust for multiple comparisons. 
3. Results 
3.1. Missing Data Analysis 
A missing data analysis was conducted on all independent variables and the missing data 
was found to be missing completely at random (MCAR) according to Little’s chi-square statistic 
(Little, 1988), 2 = 425.53, df  = 405, p = .23. 
3.2. Baseline Differences Based on NMUPD User Group 
 Table 1 reports the findings from the 2 and ANOVA tests assessing baseline differences 
in demographics and known correlates of delinquency (i.e., violence exposure, mental health, 
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other drug use, delinquency history) across patterns of NMUPD. There were significant group 
differences on all measures except SES and proportion of time spent with no community access. 
Black participants were overrepresented in the “never used NMUPD” group, whereas Hispanics 
were overrepresented in the “used NMUPD at least once in a lifetime” group. Whites and 
Hispanics were equally overrepresented in the “current NMUPD user” category. Additionally, 
NMUPD users compared to non-users were significantly older, although there were no 
differences between NMUPD at least once in lifetime and current NMUPD users. Proportionally 
more females reported NMUPD use than non-use; this was particularly evident in the current 
NMUPD use category. 
In reference to violence exposure, a linear trend was evident at baseline with more 
violence exposure being reported with more NMUPD. All three groups of NMUPD users were 
significantly different from one another on direct victimization and total violence exposure. For 
witnessed violence, youth who never used NMUPD witnessed less violence than both other 
groups of NMUPD users, who were not different from one another.  
Similarly, there were baseline NMUPD group differences in all mental health categories. 
With one exception, these differences were linear: youth with no NMUPD had a lower 
proportion of lifetime, past year, and past 30 days mental health diagnoses compared with youth 
who had used prescription drugs non-medically but not recently; those youth in turn had a lower 
proportion of diagnoses than youth who were current NMUPD users. The one exception was for 
past 30 days alcohol dependency. In that case more mental health diagnoses were found in the 
used NMUPD at least once in lifetime as compared to current NMUPD users. 
There also were significant differences at baseline between all three NMUPD groups in 
their lifetime and past 6-month use of alcohol, marijuana, and illicit drugs. The only exception 
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was lifetime marijuana use, where youth who never used NMUPD reported lower lifetime use 
than both other groups, who were not different from one another. 
Finally, there were baseline differences between the three NMUPD groups on lifetime 
and past 6 month delinquency. As NMUPD use became more frequent and recent, lifetime and 
past 6 month drug-related, non-aggressive, and aggressive delinquent acts increased. The one 
exception was that for drug-related offenses in the past 6 months the differences were between 
current NMUPD users and the other two groups. 
[INSERT TABLE 1 ABOUT HERE] 
3.3. ANCOVAs for NMUPD Predicting Future Delinquency 
3.3.1. Drug-related delinquency. NMUPD group membership significantly predicted 
future drug-related delinquency in the demographic, violence exposure, other drug use, and 
delinquency history models. In each of these models, NMUPD group membership explained 
more variance in future drug-related delinquency than the covariates (2p ranged from .03 to 
.01), except the delinquency history model. In the delinquency history model, previous drug-
related delinquency was the strongest predictor (2p = .014). As seen in Table 2, for these models 
the F statistic was diminished, indicating that the association of NMUPD with future 
delinquency was partially explained by these covariates. Within the violence exposure model, 
violence exposure was a significant predictor, with more violence exposure predicting more 
drug-related delinquency. Additionally, in the other drug use model, lifetime alcohol use was a 
significant predictor; as alcohol use increased so did drug-related delinquency. In the mental 
health model, NMUPD was no longer significant, suggesting that NMUPD does not account for 
drug-related delinquency above and beyond mental health problems.  
[INSERT TABLE 2 ABOUT HERE] 
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3.3.2. Non-aggressive delinquency. As seen in Table 3, NMUPD group membership 
significantly predicted future non-aggressive delinquency; demographic, violence exposure, 
mental health, other drug use, and delinquency history covariates also were significant in these 
models (2p ranged from .03 to .01). In the violence exposure model, violence exposure 
significantly predicted and was positively associated with non-aggressive delinquency. In the 
mental health model, increased alcohol dependency severity also predicted more non-aggressive 
delinquency. In the other drug use model, being older, more lifetime alcohol use, and more 
lifetime illicit drug use were significant predictors of increased non-aggressive delinquency. 
However, in this model lifetime alcohol use (2p = .012) was a stronger predictor of delinquency 
than NUMPD (2p = .011). In the delinquency history model, being older, more past non-
aggressive delinquency, and more past aggressive delinquency predicted increases in future non-
aggressive delinquency.  
[INSERT TABLE 3 ABOUT HERE] 
3.3.3. Aggressive delinquency. NMUPD group membership significantly predicted 
future aggressive delinquency in the demographic, violence exposure, mental health, other drug 
use, and delinquency history models with medium to small effect sizes, and explained more 
variance than the covariates in these models (2p ranged from .06 to .01), as seen in Table 4. As 
before, the association between NMUPD membership and aggressive delinquency was 
attenuated once covariates were added to the model. In all models, males and older youth were 
more likely to report aggressive delinquency. Additionally, in the violence exposure model, 
violence exposure was a significant predictor of aggressive delinquency (2p = .118), and 
stronger than NMUPD (2p = .022). Further in the mental health model, MDD severity, alcohol 
dependency severity, drug abuse severity, and drug dependency severity were additional 
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significant predictors of aggressive delinquency. In the other drug use model, lifetime alcohol 
use was a significant predictor (2p = .031), and stronger than NMUPD (
2
p = .012). In the 
delinquency history model, previous aggressive delinquency was the strongest predictor (2p = 
.102).  
[INSERT TABLE 4 ABOUT HERE] 
3.3.4. Paired contrast tests. Paired contrast tests revealed that there were significant 
group differences across all types of delinquency between youth who never engaged in NMUPD 
and current users when the F statistic was significant. Further, there were significant differences 
between youth who endorsed NMUPD at least once in their lifetime and current NMUPD users 
across all models with significant F statistics. Finally, in the demographic and mental health 
models with aggressive delinquency as the outcome, there was a significant group difference 
between adolescent offenders who never used NMUPD and those who used NMUPD at least 
once in their lifetime. 
3.3.5. Final Models. As seen in Table 5, in all final models NMUPD was no longer 
significant after accounting for the significant covariates related to each type of delinquency. A 
history of more previous drug-related delinquency was the only significant predictor of future 
drug-related delinquency after accounting for all other significant covariates. Being older and 
involved in more non-aggressive delinquency were significant predictors of future non-
aggressive delinquency, with age as the strongest predictor (2p = .006). Finally, being male and 
older, and experiencing more violence exposure, lifetime alcohol use, and previous aggressive 
delinquency were significant predictors of future aggressive delinquency. The strongest predictor 
was previous aggressive delinquency (2p = .072). 
[INSERT TABLE 5 ABOUT HERE] 
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4. Discussion 
The purpose of the present study was to examine the characteristics of NMUPD users 
among serious adolescent offenders and to evaluate the unique contribution of their NMUPD 
patterns in predicting future drug-related, non-aggressive, and aggressive delinquency. The 
unique contribution of NMUPD use patterns in predicting future delinquency, over and above 
known correlates of delinquency such as demographic characteristics, violence exposure, mental 
health diagnoses, other drug use, and delinquency history was studied. Youth with varying 
histories of NMUPD use (those who never used, used but not recently or frequently, and used 
recently and frequently) differed at baseline on race/ethnicity, age, gender, both forms of 
violence exposure, lifetime and recent mental health diagnoses, use of other drugs, and previous 
delinquency history. Moreover, with the exception of the final set of models, NMUPD was a 
significant predictor for the three distinct types of delinquency studied.  
4.1. NMUPD among Serious Adolescent Offenders  
Our findings indicated that adolescent offenders who reported engaging in NMUPD 
either currently or at some point in their lives were mostly males, White or Hispanic, and tended 
to be older than adolescent offenders who reported never engaging in NMUPD. These findings 
are consistent with previous research in the general population indicating less reports of NMUPD 
among Black youth (McCabe et al., 2012; McCauley et al., 2010; SAMHSA, 2013b; Young et 
al., 2012) and younger adolescents (SAMHSA, 2013b; Young et al., 2012). Furthermore, 
Hispanics were overrepresented in the “used NMPUD at least once in a lifetime” group; this 




 graders in the general population where 
Hispanic youth were more likely than their Black and white peers to report lifetime NMUPD 
(King, Vidourek, & Merianos, 2013).  
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While we observed more males reporting NMUPD than females, it is hard to interpret 
these results since we also observed more males reporting never engaging in NMUPD. We 
believe that these findings reflect the overrepresentation of males in all NMUPD groups in our 
sample, rather than a gender effect on the use of NMUPD. That being said, and based on the 
known association between mental health problems, other drug use and NMUPD (Catalano et al., 
2011; McCabe et al., 2012; McCauley et al., 2010), the reported higher rates of NMUPD among 
female adolescents in the general population (Califano,2005; McCauley et al., 2010) and a higher 
reported frequency of mental health problems among female offenders over their male 
counterparts (Cauffman, 2008), we believe that female adolescent offenders may present more 
NMUPD use than male adolescent offenders. This may be especially true when considering that, 
in the overall sample, female adolescents met criteria for both mood/anxiety and substance use 
disorders in higher proportions than did males (Mulvey & Schubert, 2012).   
In terms of violence exposure, adolescent offenders who engaged in NMUPD reported 
witnessing violence and experiencing more instances of direct victimization than adolescent 
offenders who have never engaged in NMUPD. Moreover, youth who reported current NMUPD 
had a higher proportion of lifetime, past year, and past 30 days mental health diagnoses when 
compared with both youth who had used prescription drugs non-medically at least once in their 
lifetime but not recently, and youth who had never engaged in NMUPD. These findings are 
consistent with previous reports of the linkages between NMUPD use among the general 
population and a history of violence exposure, PTSD, and MDD (Catalano, White, Fleming, & 
Haggerty, 2011; McCauley et al., 2010; Schepis & Krishnan-Sarin, 2008). 
Lastly, a similar pattern was observed in the reports of delinquent history and use of 
alcohol, marijuana, and illicit drugs during their lifetime and past six months. Overall, higher 
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instances of delinquent history and other drug use were reported by current NMUPD users, 
followed by adolescent offenders who used NMUPD at least once in their lifetime, with 
offenders who had never engaged in NMUPD having the fewest reports of delinquent history and 
other drug use. Once again these findings are consistent with previously reported associations 
between other drug use and increased levels of NMUPD among the general population (Boyd et 
al., 2009; Catalano et al., 2011; Ford, 2008; McCabe et al., 2012; Schepis & Krishnan-Sarin, 
2008; SAMHSA, 2013b; Wu et al., 2006; Young et al., 2012) and the strong associations 
between drug use and delinquency (Adams et al., 2013; Barnes, Welte, & Hoffman, 2002; 
Doran, Luczak, Bekman, Koutsenok, & Brown, 2012; Ford, 2008; Mason & Windle, 2002).  
Overall, a general linear pattern was observed in the data. As adolescent offenders 
reported more NMUPD use they also reported more violence exposure, mental health disorders, 
other drug use, and delinquency history at baseline. These findings corroborate reported 
associations between NMUPD, history of trauma, and other drug use among adolescent 
offenders (Alemagno, Stephens, Shaffer-King, & Teasdale, 2009; Shook et al., 2011) and 
advance our understanding of the characteristics of NMUPD users among serious juvenile 
offenders, indicating that significant differences exist depending on the severity of NMUPD.  
4.2. NMUPD and Future Delinquency 
The findings in the present study support the contribution of NMUPD in predicting drug-
related, non-aggressive, and aggressive delinquency among serious adolescent offenders beyond 
other known correlates of delinquency, with distinct differences for each type of delinquency. To 
start, when looking at each model individually we observed that overall NMUPD was a 
significant predictor of future drug-related delinquency. As we controlled for other variables in 
our analyses, NMUPD remained a significant predictor of future drug-related delinquency, 
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although the strength of the relationship was diminished. The exception to this pattern concerned 
the mental health model where NMUPD was no longer associated with drug-related delinquency 
after accounting for mental health problems. Furthermore, when demographics and all previously 
significant variables where included (i.e., total violence exposure, drug abuse severity, lifetime 
alcohol use, and drug-related delinquency history), NMUPD no longer was a significant 
predictor of future drug-related delinquency. 
Next, a similar pattern to the one described above was observed when the role of 
NMUPD in predicting non-aggressive delinquency was examined. Once again we observed that 
NMUPD group membership significantly predicted future non-aggressive delinquency while 
controlling for demographic characteristics, violence exposure, mental health, other drug use, 
and delinquency history, with a diminishing pattern in the strength of the relationship as different 
variables were considered. Furthermore, when the demographic and previously significant 
variables where included (i.e., total violence exposure, alcohol dependency severity, lifetime 
alcohol use, lifetime illicit drug use, non-aggressive delinquency history, and aggressive 
delinquency history), NMUPD group membership no longer was a significant predictor of future 
non-aggressive delinquency. Specifically being older and having engaged in more non-
aggressive delinquency in the past significantly predicted future non-aggressive delinquency.  
Additionally, NMUPD group membership was a significant predictor of future aggressive 
delinquency in the demographic, violence exposure, mental health, other drug use, and 
delinquency history models, with indication of its variance explained by the addition of other 
variables just as with drug related delinquency and non-aggressive delinquency. When all 
demographics and previously significant variables (i.e., total violence exposure, MDD severity, 
alcohol dependency severity, drug abuse severity, drug dependency severity, lifetime alcohol 
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use, and aggressive delinquency history) were included in the final model, NMUPD group 
membership no longer was a significant predictor of future aggressive delinquency. These results 
suggest that youth who engage in aggressive delinquency may have a more complex history that 
explains future aggressive delinquency as compared to those youth who engage in drug-related 
or non-aggressive delinquency. When the significant predictors are examined in terms of 
importance previous aggressive delinquency explains most of the variance, followed by total 
violence exposure, age, sex, then lifetime alcohol use. Similar to other findings, there appears to 
be a stronger connection between violence exposure and self-reported aggressive delinquency as 
compared to other forms of delinquency (Lansford et al., 2007). Also, within this unique 
population older male youth appear to be at most risk, which is similar to general populations in 
previous research (SAMHSA, 2013b). Finally, lifetime alcohol use appears to be more important 
in aggressive delinquency as compared to other types of delinquency, as well as more important 
than NMUPD. This may be because alcohol is still one of the most easily accessible substances 
for adolescents to attain (National Center on Addiction and Substance Abuse at Columbia 
University (CASA), 2012). However, with the increasing availability of prescription drugs, and 
research which suggests that youth perceive taking prescription drugs recreationally to be more 
safe than using other illicit substances (Arria, Caldeira, Vincent, O’Grady, & Wish, 2008; 
Inciardi, Surratt, Kurtz, & Cicero, 2007; Mui, Sales, & Murphy, 2013), this finding may change 
in future years if proper interventions are not enacted.  
It is noteworthy that previous history of a specific type of delinquency consistently was a 
significant predictor for its future occurrence; previous drug-related delinquency predicted future 
drug-related delinquency, previous non-aggressive delinquency predicted future non-aggressive 
delinquency, and previous aggressive delinquency predicted future aggressive delinquency. In all 
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except non-aggressive delinquency prior offending history was the strongest predictor of future 
delinquency. These findings correspond to prior reported associations between delinquency 
history and recidivism (Lipsey & Derzon, 1998; Stouthamer-Loeber et al., 2004) and again 
highlight the urgent need to develop pathways to desistance. Moreover, the importance of 
violence exposure, other drug use and mental health problems was evident. Specifically abuse 
and dependency on alcohol and drugs, as well as MDD severity need to be considered when 
conducting research and practice with adolescent offenders. Lastly, a history of violence 
exposure seemed to impact adolescent offenders across all types of offenses, highlighting the 
important role of contextual factors in prevention efforts. These findings emphasize the need to 
consider a variety of risk factors when examining delinquency. The findings also provide 
evidence that it is important to consider the pattern of delinquency, as different predictors 
emerged depending on which type of delinquency the adolescent offender reported. Also, it is 
important to consider which variables are being considered when investigating NMUPD as the 
importance of NMUPD differed depending on which covariates were included in the model. 
Without considering all of the significant variables researchers may not fully understand the 
relative important of NMUPD in future delinquency.  
Finally, severity of NMUPD matters in predicting future types of offenses; as evidenced 
by our findings. There were significant group differences across all types of delinquency 
between adolescent offenders who engaged in current NMUPD and those who never engaged in 
NMUPD. In addition, there were significant differences between youth who engaged in current 
NMUPD and those who endorsed NMUPD at least once in their lifetime. These findings 
supported the unique contribution of NMUPD in predicting future delinquency among 
adolescent offenders, and point out the important task ahead in terms of prevention efforts. The 
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results also indicate the need to assess and intervene for multiple risk factors as there were a 
variety of predictors found to be important in resulting delinquency in this at-risk population. 
4.3. Limitations 
While the study had many strengths, it is important to note limitations that may have 
impacted the results. First, this study may not adequately represent gender differences between 
groups of NMUPD users among adolescent offenders, nor gender influence in predicting future 
offenses due to the overrepresentation of males in our sample. Further, males involved in drug-
related offenses were capped, so the current sample may not be representative for all youth 
involved in drug-related delinquency. It is also possible that the predictors investigated were 
moderated by gender; this should be investigated in future studies. Additionally, due to restricted 
access to variables regarding violent offenses, we used the “aggressive offending scale” created 
by the authors of the parent study. This meant that some offenses with an arguably non-
aggressive connotation, such as property damage, were included in the analyses. Concurrent 
alcohol and other drug use were also not controlled for in all models as the authors were 
interested in the unique prediction of NMUPD. However, given the previous literature on 
polydrug use and the results of this study, future research should continue to investigate how 
NMUPD interacts with alcohol and other drug use which may predict delinquency. Finally, this 
study relied solely on adolescent self-reports which raises concerns of shared method variance 
and socially desirable responding (Kazdin, 2003). Nevertheless, the results suggest different 
characteristics of NMUPD users among adolescent offenders and an important role of NMUPD 
severity in the prediction of future delinquency.  
4.4. Implications 
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The present study significantly contributes to the understanding of NMUPD among 
adolescent offenders in several ways. As far as we know, this is the first study to specify the 
characteristics of NMUPD among adolescent offenders and to examine its relation with drug-
related, non-aggressive, and aggressive delinquency separately. Thus, several important 
implications for prevention and intervention efforts follow from the present study. First, a better 
understanding of the differences among adolescent offenders who engage in NMUPD and those 
who do not is needed in order to determine best approaches for treatment and intervention. 
Consequently, practitioners and researchers interested in promoting pathways to desistance 
would benefit from a better understanding of the findings reported, and from the identification of 
potential moderating factors both at the protective and risk levels, which allow for the design and 
implementation of prevention and treatment efforts that address those factors susceptible of 
change. Likewise, as previously noted by others (Alemagno, Stephens, Shaffer-King, & 
Teasdale, 2009; King, Vidourek, & Merianos, 2013), it is also important to understand both 
individual and contextual factors associated to the increasing rate of NMUPD among the general 
population and among adolescent offenders to inform prevention efforts. For example, an 
individual’s personality and preferred coping styles as well as parental drug or alcohol problems 
and an association with deviant peers, among others, may be influencing some of the 
associations here reported. Finally, education initiatives to promote awareness among adolescent 
offenders of the potential psychological and physical dangers that are associated with NMUPD 
use are needed. Previous research supports the use of educational strategies to reduce substance 
use among adolescents (Tolan, Szapocznik, & Sambrano, 2007) and these efforts also might be 
successfully replicated for adolescent offenders.  
4.5. Conclusion 
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NMUPD is an increasing and significant public health problem that warrants the attention 
of policy makers, researchers, and practitioners. The concern regarding NMUPD for the general 
population and adolescent offenders is well founded, especially when taking into account that the 
use of NMUPD in the general population has become more prevalent than the use of other illicit 
drugs, with the exception of marijuana (Novak, Calvin, Glasheen, & Edlund, 2011; SAMHSA, 
2013b). Adolescent offenders are a group with a particularly elevated risk of engaging in both 
substance use and continued delinquency, hence the urgent need to identify potential factors that 
may prevent desistance, such as NMUPD and the mechanism by which said factors operate.  
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Table 1 















(n = 147) 
Univariate Test of 
Difference 
Demographic Factors     





White [% (n)] 14.6 (138) 30.6 (79) 38.8 (57)  
Black [% (n)] 48.5 (458) 27.9 (72) 17.7 (26)  
Hispanic [% (n)] 32.6 (308) 34.5 (89) 38.8 (57)  
Other [% (n)] 4.3 (40) 7.0 (18) 4.7 (7)  







 15.93 (1.15) 16.36 (1.12) 16.21 (1.01) F(2, 1346) = 17.04
***
 
Mean SES (SD) 51.83 (12.63) 51.20 (11.87) 49.23 (10.71) F(2, 1338) = 2.89 
Proportion of time with no 
community access mean (SD) 0.45 (0.32) 0.50 (0.32) 0.45 (0.32) F(2, 1167) = 2.63 
Violence Exposure     
Witnessed Violence Mean (SD)
a,b
 3.51 (1.95) 4.27 (1.89) 4.63 (1.64) F(2,1346) = 32.61
***
 
Directly Victimized Mean 
(SD)
a,b,c
 1.27 (1.34) 2.09 (1.45) 2.63 (1.48) F(2,1346) = 83.51
***
 
Total Score Mean (SD)
a,b,c 
4.78 (2.85) 6.36 (2.92) 7.25 (2.77) F(2,1346) = 67.60
*** 
 















(n = 147) 
Univariate Test of 
Difference 
Mental Health     
Lifetime     
Major depressive disorder  































Past Year     
Major depressive disorder 


































2(2) = 152.58*** 
 















(n = 147) 
Univariate Test of 
Difference 
Past 30 Days     
Major depressive disorder 















Alcohol dependency [% Yes 















Other Drug Use     
Lifetime     
Alcohol use mean (SD)
a,b,c
 3.76 (2.55) 5.81 (2.48) 6.50 (2.50) F(2, 1346) = 120.67
***
 
Marijuana use mean (SD)
a,b
 5.60 (3.35) 8.08 (2.01) 8.76 (0.98) F(2, 1346) = 122.56
***
 
Illicit drug use mean (SD)
a,b,c
 0.74 (2.21) 5.19 (5.46) 9.50 (7.29) F(2,1346) = 403.26
***
 
Past 6 Months     
Alcohol use mean (SD)
a,b,c
 2.47 (2.17) 3.31 (2.56) 4.86 (2.74) F(2,1345) = 120.67
***
 
Marijuana use mean (SD)
a,b,c
 3.59 (3.23) 4.48 (3.44) 7.48 (2.46) F(2,1345) = 95.42
***
 
Illicit drug use mean (SD)
a,b,c




















(n = 147) 
Univariate Test of 
Difference 
 
Delinquency History Severity 
Index     
Lifetime     
Drug delinquency mean (SD)
a,b,c






 0.28 (0.22) 0.48 (0.22) 0.57 (0.22) F(2,1342) =98.31
***
 
Aggressive delinquency  
mean (SD)
a,b,c
 0.26 (0.18) 0.37 (0.21) 0.44 (0.23) F(2,1343) = 76.05
***
 
Past 6 Months     
Drug delinquency mean (SD)
b,c
 0.33 (0.32) 0.30 (0.36) 0.60 (0.36) F(2,841) = 39.11
***
 
Non- aggressive delinquency 
mean (SD)
a,b,c






 0.11 (0.13) 0.14 (0.13) 0.24 (0.20) F(2,1343) = 53.91
***
 
Note. Values are N (unweighted) and % (weighted) unless otherwise specified. NMUPD = Non-






p < .001. 
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a
 Significant difference (p < .05) between Group 1 and Group 2  
b
 Significant difference (p< .05) between Group 1 and Group 3  
c
 Significant difference (p< .05) between Group 2 and Group 3  
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Table 2 
ANCOVA Models for NMUPD Predicting Future Drug-Related Delinquency in Adolescent Offenders 
Category 
Model 1:  
Demographic 
Model 2:  
Violence Exposure 
Model 3:  
Mental Health 
Model 4:  
Other Drug Use 
Model 5: 
Delinquency History 
 F df 2p F df 
2
p F df 
2
p F df 
2





               
Race/Ethnicity 0.29 1,1033 .000 0.01 1,1032 .000 0.71 1,993 .001 0.26 1,1030 .000 0.00 1,1028 .000 
Sex  2.07 1,1033 .002 0.79 1,1032 .001 1.92 1,993 .002 1.64 1,1030 .002 0.13 1,1028 .000 
Age 0.08 1,1033 .000 0.05 1,1032 .000 0.01 1,993 .000 0.23 1,1030 .000 0.72 1,1028 .001 
SES 2.65 1,1033 .003 2.21 1,1032 .002 4.49
*
 1,993 .005 3.38 1,1030 .003 2.62 1,1028 .003 
Proportion of time 
with no community 
access 
0.00 1,1033 .000 0.14 1,1032 .000 0.02 1,993 .000 0.08 1,1030 .000 0.44 1,1028 .000 
                
Violence Exposure                
Total violence 
exposure 
   13.89
*** 
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Category 
Model 1:  
Demographic 
Model 2:  
Violence Exposure 
Model 3:  
Mental Health 
Model 4:  
Other Drug Use 
Model 5: 
Delinquency History 
 F df 2p F df 
2
p F df 
2
p F df 
2





               
MDD        3.05 1,993 .003       
PTSD        0.56 1,993 .001       
Alcohol abuse        0.35 1,993 .000       
Alcohol 
dependency  
      3.76 1,993 .004       
Drug abuse        7.67
** 
1,993 .008       
Drug dependency        2.40 1,993 .002       
       
 
        
Other drug use                
Lifetime alcohol 
use 
         5.63
*
 1,1030 .005    
Lifetime marijuana 
use  
         3.10 1,1030 .003    
Lifetime illicit drug 
use  
         0.02 1,1030 .000    
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Category 
Model 1:  
Demographic 
Model 2:  
Violence Exposure 
Model 3:  
Mental Health 
Model 4:  
Other Drug Use 
Model 5: 
Delinquency History 
 F df 
2
p F df 
2
p F df 
2
p F df 
2





               
Drug-related             14.11
*** 
1,1028 .014 
Non-aggressive             0.10 1,1028 .000 
Aggressive             2.98 1,1028 .003 
                
NMUPD Group 
           





































Note. MDD = Major depressive disorder, NMUPD = Non-medical use of prescription drugs, PTSD = Post traumatic stress disorder, 
SES = Socioeconomic status. 
*
 p < .05. 
**
 p < .01. 
*** 
p < .001. 
a
 Significant difference (p < .05) between Group 1: Never Used NMUPD and Group 3: Current NMUPD Users 
b
 Significant difference (p < .05) between Group : Used NMUPD in Lifetime 2 and Group 3: Current NMUPD Users 
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Table 3 
ANCOVA Models for NMUPD Predicting Future Non-Aggressive Delinquency in Adolescent Offenders 
Category 
Model 1:  
Demographic 
Model 2:  
Violence Exposure 
Model 3:  
Mental Health 
Model 4:  
Other Drug Use 
Model 5: 
Delinquency History 
 F df 2p F df 
2
p F df 
2
p F df 
2





               
Race/Ethnicity 
0.71 1,1033 .001 1.91 1,1032 .001 0.18 1,993 .000 0.09 1,1030 .000 0.98 1,1028 .001 
Sex  
2.11 1,1033 .002 0.97 1,1032 .001 1.91 1,993 .002 1.50 1,1030 .001 0.05 1,1028 .000 
Age 
2.36 1,1033 .002 3.84 1,1032 .004 3.28 1,993 .003 5.18
*
 1,1030 .005 4.79
*
 1,1028 .005 
SES 
0.91 1,1033 .001 0.68 1,1032 .001 1.27 1,993 .001 1.96 1,1030 .002 1.36 1,1028 .001 
Proportion of time 
with no 
community access 
0.13 1,1033 .000 0.00 1,1032 .000 0.17 1,993 .000 0.03 1,1030 .000 0.04 1,1028 .000 
                
Violence 
Exposure 
               
Total violence 
exposure 
   9.99
** 
1,1032 .010          
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Category 
Model 1:  
Demographic 
Model 2:  
Violence Exposure 
Model 3:  
Mental Health 
Model 4:  
Other Drug Use 
Model 5: 
Delinquency History 
 F df 2p F df 
2
p F df 
2
p F df 
2





               
MDD        0.62 1,993 .001       
PTSD        0.79 1,993 .001       
Alcohol abuse        0.66 1,993 .001       
Alcohol 
dependency  
      7.91
** 
1,993 .008       
Drug abuse        0.02 1,993 .000       
Drug dependency        0.02 1,993 .006       
       
 
        
Other drug use                
Lifetime alcohol 
use 
         12.90
*** 
1,1030 .012    
Lifetime 
marijuana use  
         0.01 1,1030 .000    
Lifetime illicit 
drug use  
         3.91
* 
1,1030 .004    
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Category 
Model 1:  
Demographic 
Model 2:  
Violence Exposure 
Model 3:  
Mental Health 
Model 4:  
Other Drug Use 
Model 5: 
Delinquency History 
 F df 
2
p F df 
2
p F df 
2
p F df 
2





               
Drug-related 
            0.52 1,1028 .001 
Non-aggressive 
            6.28
*
 1,1028 .006 
Aggressive 
            5.63
*
 1,1028 .005 
                
NMUPD Group 
           








           
























       








Note. MDD = Major depressive disorder, PTSD = Post traumatic stress disorder, SES = Socioeconomic status. 
*
 p < .05. 
**
 p < .01. 
*** 
p < .001. 
a
 Significant difference (p < .05) between Group 1: Never Used NMUPD and Group 3: Current NMUPD Users 
b
 Significant difference (p < .05) between Group : Used NMUPD in Lifetime 2 and Group 3: Current NMUPD Users 
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Table 4 
ANCOVA Models for NMUPD Predicting Future Aggressive Delinquency in Adolescent Offenders 
Category 
Model 1:  
Demographic 
Model 2:  
Violence Exposure 
Model 3:  
Mental Health 
Model 4:  
Other Drug Use 
Model 5: 
Delinquency History 
 F df 2p F df 
2
p F df 
2
p F df 
2





               
Race/Ethnicity 




 1,1033 .029 18.44
***










 1,1033 .006 18.59
***
 1,1032 .016 8.01
**
 1,993 .007 16.15
***
 1,1030 .014 14.21
***
 1,1028 .013 
SES 
1.62 1,1033 .001 3.04 1,1032 .003 1.14 1,993 .001 0.53 1,1030 .000 1.68 1,1028 .002 
Proportion of time 
with no community 
access 
1.70 1,1033 .002 0.05 1,1032 .000 1.47 1,993 .001 0.76 1,1030 .001 0.01 1,1028 .000 
                
Violence 
Exposure 
               
Total violence 
exposure 
   147.93
*** 
1,1032 .118          
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Category 
Model 1:  
Demographic 
Model 2:  
Violence Exposure 
Model 3:  
Mental Health 
Model 4:  
Other Drug Use 
Model 5: 
Delinquency History 
 F df 2p F df 
2
p F df 
2
p F df 
2





               
MDD        4.84
*
 1,993 .004       
PTSD        1.15 1,993 .001       
Alcohol abuse        3.41 1,993 .003       
Alcohol 
dependency  
      7.33
** 
1,993 .007       
Drug abuse        5.40
*
 1,993 .007       
Drug dependency        10.07
**
 1,993 .009       
       
 
        
Other drug use                
Lifetime alcohol 
use 
         35.33
*** 
1,1030 .031    
Lifetime marijuana 
use  
         3.70 1,1030 .003    
Lifetime illicit drug 
use  
         3.48 1,1030 .003    
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Category 
Model 1:  
Demographic 
Model 2:  
Violence Exposure 
Model 3:  
Mental Health 
Model 4:  
Other Drug Use 
Model 5: 
Delinquency History 
 F df 
2
p F df 
2
p F df 
2
p F df 
2





               
Drug-related 
            0.19 1,1028 .000 
Non-aggressive 
            0.51 1,1028 .000 
Aggressive 
            125.46
*** 
1,1028 .102 
                
NMUPD Group 








           


































Note. MDD = Major depressive disorder, PTSD = Post traumatic stress disorder, SES = Socioeconomic status. 
*
 p < .05. 
**
 p < .01. 
*** 
p < .001. 
a
 Significant difference (p < .05) between Group 1: Never Used NMUPD and Group 2: Used NMUPD in Lifetime 
b
 Significant difference (p < .05) between Group 1: Never Used NMUPD and Group 3: Current NMUPD Users 
c
 Significant difference (p < .05) between Group : Used NMUPD in Lifetime 2 and Group 3: Current NMUPD Users 
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Table 5  
Final ANCOVA Models for NMUPD Predicting Future Delinquency in Adolescent Offenders 
Final Models F df p 2p 
Drug-related delinquency     
Race/Ethnicity 0.05 1,993 .827 .000 
Sex  0.23 1,993 .635 .000 
Age 1.07 1,993 .301 .001 
SES 3.75 1,993 .053 .004 
Proportion of time with no community access 0.40 1,993 .530 .000 
Total violence exposure 3.11 1,993 .078 .003 
Drug abuse severity 1.61 1,993 .205 .002 
Lifetime alcohol use 2.18 1,993 .140 .002 
Drug-related delinquency history 12.13 1,993 .001 .012 
NMUPD 2.07 2, 993 .127 .004 
     
Non-aggressive delinquency     
Race/Ethnicity 0.09 1,991 .764 .000 
Sex  0.11 1,991 .683 .000 
Age 5.54
 
1,991 .019 .006 
SES 2.27 1,991 .141 .002 
Proportion of time with no community access 0.08 1,991 .928 .000 
Total violence exposure 0.11 1,991 .745 .000 
Alcohol dependencyseverity 2.21 1,991 .137 .002 
Lifetime alcohol use 2.96 1,991 .086 .003 
Lifetime illicit drug use 1.72 1,991 .190 .002 
Non-aggressive delinquency history 5.13
 
1,991 .024 .005 
Aggressive delinquency history 2.89 1,991 .089 .003 
NMUPD 1.85 2, 991 .158 .004 
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Final Models F df p 2p 
Aggressive delinquency     
Race/Ethnicity 0.64 1,1068 .423 .001 
Sex  10.77
 
1,1068 .001 .010 
Age 20.74
 
1,1068 < .001 .019 
SES 1.72 1,1068 .190 .002 
Proportion of time with no community access 0.13 1,1068 .716 .000 
Total violence exposure 24.53
 
1,1068 < .001 .022 
MDD severity 1.42 1,1068 .233 .001 
Alcohol dependency severity 0.95 1,1068 .331 .001 
Drug abuse severity 0.02 1,1068 .897 .000 
Drug dependency severity 0.88 1,1068 .348 .001 
Lifetime alcohol use 8.95
 
1,1068 .003 .008 
Aggressive delinquency history 82.41
 
1,1068 < .001 .072 
NMUPD 1.82 2,1068 .162 .003 
Note. MDD = Major depressive disorder, NMUPD = Non-medical use of prescription drugs, 
SES = Socioeconomic status. 
 
 
